West Pharmaceutical (WST) PT Raised to $365 at UBS
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $347.94 -1.23%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
UBS analyst Gregg Orrill raised the price target on West Pharmaceutical (NYSE: WST) to $365.00 (from $356.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Hyperion DeFi, Inc. (HYPD) PT Raised to $7.10 at Cantor Fitzgerald
- CAVA Group Inc (CAVA) PT Lowered to $75 at DA Davidson Following Q2 Results
- Viking Holdings (VIK) PT Raised to $125 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
